Aaron LeBeau, PhD, discusses the potential wide applicability of shark antibodies in developing imaging and therapeutic strategies in prostate cancer.
Aaron LeBeau, PhD
Advertisement
Articles by Aaron LeBeau, PhD
Aaron LeBeau, PhD, discusses the potential of shark variable domain of new antigen receptor proteins in prostate cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026
2
ctDNA Status Has Strong Prognostic Value, Outperforming pCR Status, in Early TNBC
3
Aglatimagene Besadenovec Plus EBRT Improves Prostate Cancer-Specific DFS
4
Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026
5